Close Menu

NEW YORK – Investigators from the Dana-Farber Cancer Institute are making progress implementing an innovative computational program that they developed to match patients to precision medicine clinical trials based on results from genomic profiling tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.